Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: Potential implications in metabolic disorders

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 291-308

  Chaturvedi, Nagendra Kumar ^a   Kumar, Sanjay ^a   Negi, Seema ^a   Tyagi, Rakesh K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Androgen receptor; Endocrine disruptors; Green fluorescent protein; Mitotic chromatin; Pregnane and xenobiotic receptor

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; ANDROGEN RECEPTOR; ANDROSTANOLONE; CHLORPHENOTANE; CYTOCHROME P450 3A11; DEXAMETHASONE; DIFENOCONAZOLE; ENDOCRINE DISRUPTOR; FENITROTHION; FLAME RETARDANT; GR INTERACTING PROTEIN 1; LINURON; METHOXYCHLOR; MULTIDRUG RESISTANCE PROTEIN 1; NITROFEN; PREGNANE X RECEPTOR; PROCYMIDONE; PROTEIN; TATA BINDING PROTEIN; TETRAMETHRIN; UNCLASSIFIED DRUG; VINCLOZOLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; LONG TERM EXPOSURE; MALE; METABOLIC DISORDER; MITOSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEAR IMPORT; PROMOTER REGION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SCREENING; TRANSCRIPTION TERMINATION; UPREGULATION;

ANDROGENS; ANIMALS; ENDOCRINE DISRUPTORS; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KINETICS; MALE; MICE; RECEPTORS, ANDROGEN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION, GENETIC;

MUS;

EID: 78449268305     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0583-6     Document Type: Article

References (97)

1. AK Roy RK Tyagi CS Song Y Lavrovsky SC Ahn TS Oh B Chatterjee 2001 Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction Ann NY Acad Sci 949 44 57 10.1111/j.1749-6632.2001. tb04001.x 11795379
2. Bagchi G, Moniri NH, Daaka Y (2006) Androgen receptor. UCSD-Nature Molecule Pages. doi: 10.1038/mp.a003790.01
3. SM Dehm DJ Tindall 2007 Androgen receptor structural and functional elements: role and regulation in prostate cancer Mol Endocrinol 21 2855 2863 10.1210/me.2007-0223 17636035
4. RK Tyagi Y Lavrovsky SC Ahn CS Song B Chatterjee AK Roy 2000 Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells Mol Endocrinol 14 1162 1174 10.1210/me.14.8.1162 10935541
5. BE Black BM Paschal 2004 Intranuclear organization and function of the androgen receptor Trends Endocrinol Metab 15 411 417 15519887
6. S Kumar M Saradhi NK Chaturvedi RK Tyagi 2006 Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview Mol Cell Endocrinol 246 147 156 10.1016/j.mce.2005.11.028 16388893
7. CA Berrevoets A Umar AO Brinkmann 2002 Antiandrogens: selective androgen receptor modulators Mol Cell Endocrinol 198 97 103 10.1016/S0303-7207(02)00373-8 12573819
8. L Wang CL Hsu C Chang 2005 Androgen receptor corepressors: an overview Prostate 63 117 130 10.1002/pros.20170 15486994
9. HV Heemers DJ Tindall 2007 Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex Endocr Rev 28 778 808 10.1210/er.2007-0019 17940184
10. S Kumar NK Chaturvedi S Kumar RK Tyagi 2008 Agonist-mediated docking of androgen receptor onto the mitotic chromatin platform discriminates intrinsic mode of action of prostate cancer drugs Biochim Biophys Acta 1783 59 73 10.1016/j.bbamcr.2007.11.002 18070607
11. M Saradhi A Sengupta G Mukhopadhyay RK Tyagi 2005 Pregnane and xenobiotic receptor (PXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis Biochim Biophys Acta 1746 85 94 10.1016/j.bbamcr.2005.10.004 16297466
12. M Saradhi N Kumar RC Reddy RK Tyagi 2006 Pregnane and xenobiotic receptor (PXR): a promiscuous xenosensor with a role in human health and disease J Endocrinol Reprod 10 1 12
13. M Matic A Mahns M Tsoli A Corradin P Polly GR Robertson 2007 Pregnane X receptor: promiscuous regulator of detoxification pathways Int J Biochem Cell Biol 39 478 483 10.1016/j.biocel.2006.08.017 17188925
14. SA Kliewer JT Moore L Wade JL Staudinger MA Watson SA Jones DD McKee BB Oliver TM Willson RH Zetterström T Perlmann JM Lehmann 1998 An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway Cell 92 73 82 10.1016/S0092-8674(00)80900-9 9489701
15. B Blumberg W Sabbagh Jr H Juguilon J Bolado Jr M Van Meterc ES Ong RM Evans 1998 SXR, a novel steroid and xenobiotic-sensing nuclear receptor Genes Dev 12 3195 3205 10.1101/gad.12.20.3195 9784494
16. J Orans DG Teotico MR Redinbo 2005 The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges Mol Endocrinol 19 2891 2900 10.1210/me.2005-0156 15961506
17. LA Stanley BC Horsburgh J Ross N Scheer CR Wolf 2006 PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity Drug Metab Rev 38 515 597 10.1080/03602530600786232 16877263
18. M Ogino K Nagata Y Yamazoe 2002 Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7 by troglitazone in HepG2 cells Drug Metab Pharmacokinet 17 42 46 10.2133/dmpk.17.42 15618651
19. B Goodwin E Hodgson C Liddle 1999 The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module Mol Pharmacol 56 1329 1339 10570062
20. SA Wrighton EG Schuetz KE Thummel DD Shen KR Korzekwa PB Watkins 2000 The human CYP3A subfamily: practical considerations Drug Metab Rev 32 339 361 10.1081/DMR-100102338 11139133
21. LB Moore B Goodwin SA Jones GB Wisely CJ Serabijt-Singh TM Willson JL Collins SA Kliewer 2000 St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc Natl Acad Sci USA 97 7500 7502 10.1073/pnas.130155097 10852961
22. H Huang H Wang M Sinz M Zoeckler J Staudinger MR Redinbo DG Teotico J Locker GV Kalpana S Mani 2007 Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole Oncogene 26 258 268 10.1038/sj.onc.1209788 16819505
23. C Zhou EJ Poulton F Grun TK Bammler B Blumberg KE Thummel DL Eaton 2007 The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor Mol Pharmacol 71 220 229 10.1124/mol.106.029264 17028159
24. S Ekins V Kholodovych N Ai M Sinz J Gal L Gera WJ Welsh K Bachmann S Mani 2008 Computational discovery of novel low micromolar human pregnane X receptor antagonists Mol Pharmacol 74 662 672 10.1124/mol.108.049437 18579710
25. H Wang H Li LB Moore MD Johnson JM Maglich B Goodwin OR Ittoop B Wisely K Creech DJ Parks JL Collins TM Willson GV Kalpana M Venkatesh W Xie SY Cho J Roboz M Redinbo JT Moore S Mani 2008 The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor Mol Endocrinol 22 838 857 10.1210/me.2007-0218 18096694
26. A Biswas S Mani MR Redinbo MD Krasowski H Li S Ekins 2009 Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists Pharm Res 26 1807 1815 10.1007/s11095-009-9901-7 19415465
27. SA Kliewer 2005 Pregnane X receptor: predicting and preventing drug interactions Thromb Res 117 133 136 10.1016/j.thromres.2005.07.001 16087223
28. JL Staudinger X Ding K Lichti 2006 Pregnane X receptor and natural products: beyond drug-drug interactions Expert Opin Drug Metab Toxicol 2 847 857 10.1517/17425255.2.6.847 17125405
29. RG Tirona W Lee BF Leake LB Lan CB Cline V Lamba F Parviz A Duncan Y Inoue FJ Gonzalez EG Schuetz RB Kim 2003 The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4 Nat Med 9 220 224 10.1038/nm815 12514743
30. Y Chen G Kissling M Negishi JA Goldstein 2005 The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter J Pharmacol Exp Ther 314 1125 1133 10.1124/jpet.105.087072 15919766
31. C Zhou MM Tabb EL Nelson F Grün S Verma A Sadatrafiei M Lin S Mallick BM Forman KE Thummel B Blumberg 2006 Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation J Clin Invest 116 2280 2289 10.1172/JCI26283 16841097
32. W Mnif JM Pascussi A Pillon A Escande A Bartegi JC Nicolas V Cavaillès MJ Duchesne P Balaguer 2007 Estrogens and antiestrogens activate hPXR Toxicol Lett 170 19 29 10.1016/j.toxlet.2006.11.016 17379461
33. C Zhou S Verma B Blumberg 2009 The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism Nucl Recept Signal 7 e001 19240808
34. YP Lim JD Huang 2008 Interplay of pregnane X receptor with other nuclear receptors on gene regulation Drug Metab Pharmacokinet 23 14 21 10.2133/dmpk.23.14 18305371
35. Y Konno S Kodama R Moore N Kamiya M Negishi 2009 Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation Mol Pharmacol 75 265 271 10.1124/mol.108.051904 18981260
36. S Kumar B Jaiswal S Kumar S Negi RK Tyagi 2010 Cross-talk between androgen receptor and pregnane and xenobiotic receptor reveals existence of a novel modulatory action of antiandrogenic drugs Biochem Pharmacol 80 964 976 10.1016/j.bcp.2010.06.009 20599793
37. H Masuyama Y Hiramatsu J Kodama T Kudo 2003 Expression and potential roles of pregnane X receptor in endometrial cancer J Clin Endocrinol Metab 88 4446 4454 10.1210/jc.2003-030203 12970323
38. Y Chen Y Tang MT Wang S Zeng D Nie 2007 Human pregnane X receptor and resistance to chemotherapy in prostate cancer Cancer Res 67 10361 10367 10.1158/0008-5472.CAN-06-4758 17974979
39. H Masuyama H Nakatsukasa N Takamoto Y Hiramatsu 2007 Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells Mol Pharmacol 72 1045 1053 10.1124/mol.107.037937 17636047
40. D Gupta M Venkatesh H Wang S Kim M Sinz GL Goldberg K Whitney C Longley S Mani 2008 Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer Clin Cancer Res 14 5332 5340 10.1158/1078-0432.CCR-08-1033 18765524
41. A Moreau MJ Vilarem P Maurel JM Pascussi 2008 Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response Mol Pharm 5 35 41 10.1021/mp700103m 18159929
42. S Verma MM Tabb B Blumberg 2009 Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells BMC Cancer 5 3 9 10.1186/1471-2407-9-3
43. C Raynal JM Pascussi G Leguelinel C Breuker J Kantar B Lallemant S Poujol C Bonnans D Joubert F Hollande S Lumbroso JP Brouillet A Evrard 2010 Pregnane X receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation Mol Cancer 9 46 10.1186/1476-4598-9-46 20196838
44. D Takeyama Y Miki F Fujishima T Suzuki J Akahira S Hata G Miyata S Satomi H Sasano 2010 Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: a potent prognostic factor Cancer Sci 101 543 549 10.1111/j.1349-7006.2009.01380.x 19860844
45. K Satoh F Nagai N Aoki 2001 Several environmental pollutants have binding affinities for both androgen receptor and estrogen receptor alpha J Health Sci 47 495 501 10.1248/jhs.47.495
46. I Ben-Shlomo AJ Hsueh 2005 Three's company: two or more unrelated receptors pair with the same ligand Mol Endocrinol 19 1009 1097 10.1210/me.2004-0451
47. WR Kelce EM Wilson 1997 Environmental antiandrogens: development effects, molecular mechanisms, and clinical implications J Mol Med 75 198 207 10.1007/s001090050104 9106076
48. LE Gray Jr J Ostby J Furr CJ Wolf C Lambright L Parks DN Veeramachaneni V Wilson M Price A Hotchkiss E Orlando L Guillette 2001 Effect of environmental antiandrogens on reproductive development in experimental animals Hum Reprod Update 7 248 264 10.1093/humupd/7.3.248 11392371
49. M Irma EG Medina-Diaz 2005 Transcriptional induction of CYP3A4 by o, p′-DDT in HepG2 cells Toxicol Lett 157 41 47 10.1016/j.toxlet.2005.01.003
50. A Larsson LA Eriksson PL Andersson P Ivarson PE Olsson 2006 Identification of the brominated flame retardant 1, 2-dibromo-4-(1, 2-dibromoethyl)cyclohexane as an androgen agonist J Med Chem 49 7366 7372 10.1021/jm060713d 17149866
51. AC Gore JJ Heindel RT Zoeller 2006 Endocrine disruption for endocrinologists (and others) Endocrinology 147 S1 S3 10.1210/en.2005-1367 16690798
52. LJ Guillette Jr 2006 Endocrine disrupting contaminants-beyond the dogma Environ Health Perspect 114 9 12 10.1289/ehp.8045 16818240
53. J Janosek K Hilscherová L Bláha I Holoubek 2006 Environmental xenobiotics and nuclear receptors-interactions, effects and in vitro assessment Toxicol In Vitro 20 18 37 10.1016/j.tiv.2005.06.001 16061344
54. JJ Heindel 2007 Role of exposure to environmental chemicals in the developmental basis of disease and dysfunction Reprod Toxicol 23 257 259 10.1016/j.reprotox.2007.01.006 17331698
55. M Joffe 2001 Are problems with male reproductive health caused by endocrine disruption? Occup Environ Med 58 281 287 10.1136/oem.58.4.281 11245747
56. M Uzumcu R Zachow 2007 Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function Reprod Toxicol 23 337 352 10.1016/j.reprotox.2006.10.006 17140764
57. CM Lathers 2002 Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment J Clin Pharmacol 42 7 23 10.1177/0091270002042001001 11808826
58. S Safe 2004 Endocrine disruptors and human health: is there a problem Toxicology 205 3 10 10.1016/j.tox.2004.06.032 15458784
59. WJ Rogan A Chen 2005 Health risks and benefits of bis(4-chlorophenyl)-1, 1, 1-trichloroethane (DDT) Lancet 366 763 773 10.1016/S0140-6736(05)67182-6 16125595
60. United States Environmental Protection Agency (1997) Special report on environmental endocrine disruption: an effects assessment and analysis. Office of Prevention, Pesticides and Toxic Substances, Washington
61. C Sultan P Balaguer B Terouanne V Georget F Paris C Jeandel S Lumbroso JC Nicolas 2001 Environmental xenoestrogens, antiandrogens, and disorders of male sexual differentiation Mol Cell Endocrinol 178 99 105 10.1016/S0303-7207(01) 00430-0 11403899
62. MM Tabb B Blumberg 2006 New modes of action for endocrine-disrupting chemicals Mol Endocrinol 20 475 482 10.1210/me.2004-0513 16037129
63. S Kumar NK Chaturvedi M Nishi M Kawata RK Tyagi 2004 Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1 independent pathway Biochim Biophys Acta 1691 73 77 10.1016/j.bbamcr.2004.03.003 15110988
64. H Kojima E Katsura S Takeuchi K Niiyama K Kobayashi 2004 Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells Environ Health Perspect 112 524 531 10.1289/ehp.6649 15064155
65. N Araki K Ohno M Nakai M Takeyoshi M Iida 2005 Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells Toxicol In Vitro 19 831 842 10.1016/j.tiv.2005.04.009 15950433
66. CY Zhao RS Zhang HX Zhang CX Xue HX Liu MC Liu ZD Hu BT Fan 2005 QSAR study of natural, synthetic and environmental endocrine disrupting compounds for binding to the androgen receptor SAR QSAR Environ Res 16 349 3467 10.1080/10659360500204368 16234176
67. V Berno CA Hinojos L Amazit AT Szafran MA Mancini 2006 High-resolution, high-throughput microscopy analyses of nuclear receptor and coregulator function Methods Enzymol 414 188 210 10.1016/S0076-6879(06)14011-2 17110193
68. R Pepperkok J Ellenberg 2006 High-throughput fluorescence microscopy for systems biology Nat Rev Mol Cell Biol 7 690 696 10.1038/nrm1979 16850035
69. AT Szafran M Szwarc M Marcelli MA Mancini 2008 Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects PLoS ONE 3 e3605 10.1371/journal.pone. 0003605 18978937
70. JO Jones WF An MI Diamond 2009 AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization ACS Chem Biol 4 191 197 10.1021/cb900024z
71. G Neurohr DW Gerlich 2009 Assays for mitotic chromosome condensation in live yeast and mammalian cells Chromosome Res 17 145 154 10.1007/s10577-008- 9010-1 19308697
72. S Zhang M Danielsen 2001 Cotransfection assays and steroid receptor biology Methods Mol Biol 176 297 316 11554330
73. G Lemaire G de Sousa R Rahmani 2004 A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides Biochem Pharmacol 68 2347 2358 10.1016/j.bcp.2004.07.041 15548381
74. RK Tyagi 2003 Dynamics of subcellular compartmentalization of steroid receptors in living cells as a strategic screening method to determine the biological impact of suspected endocrine disruptors Med Hypotheses 60 501 504 10.1016/S0306-9877(02)00442-5 12615508
75. M Agler M Prack Y Zhu J Kolb K Nowak R Ryseck D Shen ME Cvijic J Somerville S Nadler T Chen 2007 A high-content glucocorticoid receptor translocation assay for compound mechanism-of-action evaluation J Biomol Screen 12 1029 1041 10.1177/1087057107309353 17989426
76. A Tomura K Goto H Morinaga M Nomura T Okabe T Yanase R Takayanagi H Nawata 2001 The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein J Biol Chem 276 28395 28401 10.1074/jbc.M101755200 11369770
77. D Chen CS Hinkley RW Henry S Huang 2002 TBP dynamics in living human cells: constitutive association of TBP with mitotic chromosomes Mol Biol Cell 13 276 284 10.1091/mbc.01-10-0523 11809839
78. GG Gibson NJ Plant KE Swales A Ayrton W El-Sankary 2002 Receptor dependent transcriptional activation of cytochrome P450 3A genes: induction mechanisms, species differences and interindividual variation in man Xenobiotica 32 165 206 10.1080/00498250110102674 11958559
79. XC Kretschmer WS Baldwin 2005 CAR and PXR: xenosensors of endocrine disruptors? Chem Biol Interact 155 111 128 10.1016/j.cbi.2005.06.003 16054614
80. O Levillain JJ Diaz O Blanchard H Déchaud 2005 Testosterone down-regulates ornithine aminotransferase gene and up-regulates arginase II and ornithine decarboxylase genes for polyamines synthesis in the murine kidney Endocrinology 146 950 959 10.1210/en.2004-1199 15539552
81. AM Vinggaard H Jacobsen SB Metzdorff HR Andersen C Nellemann 2005 Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol Toxicology 207 21 34 10.1016/j.tox.2004.08.009 15590119
82. A Domanskyi FP Zhang M Nurmio JJ Palvimo J Toppari OA Jänne 2007 Expression and localization of androgen receptor-interacting protein-4 in the testis Am J Physiol Endocrinol Metab 292 E513 E522 10.1152/ajpendo.00287.2006 17003240
83. S Shanker Z Hu MF Wilkinson 2008 Epigenetic regulation and downstream targets of the Rhox5 homeobox gene Int J Androl 31 462 470 10.1111/j.1365-2605. 2008.00904.x 18637153
84. T Yanagimoto S Itoh D Muller-Enoch T Kamataki 1992 Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone Biochim Biophys Acta 130 329 332
85. MJ Down S Arkle JJ Mills 2007 Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver Arch Biochem Biophys 457 105 110 10.1016/j.abb.2006.09.017 17107656
86. YH Chen JP Wang H Wang MF Sun LZ Wei W Wei DX Xu 2005 Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta Toxicology 211 242 252 10.1016/j.tox.2005.03.011 15869837
87. AD Mottino VA Catania 2008 Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents World J Gastroenterol 14 7068 7074 10.3748/wjg.14.7068 19084913
88. BB Yeap RG Krueger PJ Leedman 1999 Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells Endocrinology 140 3282 3291 10.1210/en.140.7.3282 10385425
89. T Furutani T Watanabe K Tanimoto T Hashimoto H Koutoku M Kudoh Y Shimizu S Kato H Shikama 2002 Stabilization of androgen receptor protein is induced by agonist, not by antagonists Biochem Biophys Res Commun 294 779 784 10.1016/S0006-291X(02)00564-8 12061774
90. H Masuyama H Inoshita Y Hiramatsu T Kudo 2002 Ligands have various potential effects on the degradation of pregnane X receptor by proteasome Endocrinology 143 55 61 10.1210/en.143.1.55 11751591
91. Y Ma K Sachdeva J Liu X Song Y Li D Yang R Deng CO Chichester B Yan 2005 Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23 Biochem Pharmacol 69 1363 1371 10.1016/j.bcp.2005.02.011 15826607
92. S Safe S Papineni 2006 The role of xenoestrogenic compounds in the development of breast cancer Trends Pharmacol Sci 27 447 454 10.1016/j.tips.2006.06.006 16822555
93. RM Sharpe 2006 Pathways of endocrine disruption during male sexual differentiation and masculinization Best Pract Res Clin Endocrinol Metab 20 91 110 10.1016/j.beem.2005.09.005 16522522
94. AD Goldberg CD Allis E Bernstein 2007 Epigenetics: a landscape takes shape Cell 128 635 638 10.1016/j.cell.2007.02.006 17320500
95. MD Anway AS Cupp M Uzumcu MK Skinner 2005 Epigenetic transgenerational actions of endocrine disruptors and male fertility Science 308 1466 1469 10.1126/science.1108190 15933200
96. MD Anway SR Stephen MK Skinner 2008 Transgenerational epigenetic programming of the embryonic testis transcriptome Genomics 91 30 40 10.1016/j.ygeno.2007.10.002 18042343
97. Z Herceg 2007 Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis 22 91 103 10.1093/mutage/ gel068 17284773